Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,365,198
+$598,054 QoQ
Shares Held
17,347
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#1,399
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prestige Wealth Management Group LLC holds $26,909,774 across 14 Drug Manufacturers - General names. ABBV ranks #4 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
33,173 | $8,424,946 | |
| 2 | LLY |
ELI LILLY & Co
|
4,518 | $5,419,024 | |
| 3 | MRK |
Merck & Co., Inc.
|
36,409 | $4,678,556 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
17,347 | $4,365,198 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,647 | $1,189,679 | |
| 6 | AMGN |
Amgen Inc
|
3,138 | $1,136,331 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,232 | $913,690 | |
| 8 | PFE |
Pfizer Inc
|
17,600 | $423,807 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,365,198 | 17,347 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $3,767,144 | 17,321 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $3,972,526 | 17,386 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $2,823,861 | 12,196 | Shares | Sole | 2026-02-20 | |
| 2025-06-30 | $853,851 | 4,600 | Shares | Sole | 2026-02-20 | |
| 2025-03-31 | $935,925 | 4,467 | Shares | Sole | 2026-02-20 | |
| 2024-12-31 | $776,193 | 4,368 | Shares | Other | 2026-02-20 | |
| 2024-09-30 | $814,209 | 4,123 | Shares | Other | 2026-02-20 | |
| 2024-06-30 | $641,312 | 3,739 | Shares | Other | 2026-02-20 | |
| 2024-03-31 | $117,454 | 645 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $141,487 | 913 | Shares | Other | 2024-04-26 | |
| 2023-09-30 | $148,612 | 997 | Shares | Other | 2024-04-26 | |
| 2023-06-30 | $139,983 | 1,039 | Shares | Sole | 2024-04-26 | |
| 2023-03-31 | $954,466 | 5,989 | Shares | Other | 2024-04-26 | |
| 2022-12-31 | $192,477 | 1,191 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $725,001 | 5,402 | Shares | Other | 2022-11-01 | |
| 2022-06-30 | $751,709 | 4,908 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $758,674 | 4,680 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $161,532 | 1,193 | Shares | Other | 2022-02-15 | |
| 2021-09-30 | $126,962 | 1,177 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $61,726 | 548 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $59,303 | 548 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $58,074 | 542 | Shares | Other | 2021-02-17 | |
| 2020-09-30 | $31,619 | 361 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $35,442 | 361 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $135,008 | 1,772 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||